Skip to main content
AKTX
NASDAQ Life Sciences

Q3 Cash of $5.7M Leaves Akari With Runway Only Into Q1 2027

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$6.51
Mkt Cap
$13.041M
52W Low
$3.015
52W High
$29.32
52W Position info
116% above low
Off High info
78% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

AKTX has more than doubled off its 52-week low of $3.015 on light trading volume (0.2× avg).

Summary

Akari closed Q3 2026 with $5.7M in cash, up from $5.2M at Dec. 31, 2025, after pulling in roughly $2.9M from warrant exercises and repaying $0.7M of convertible notes, leaving none outstanding. The company's own 10-Q, filed today, carries explicit substantial doubt about its ability to continue as a going concern, with runway only into the first quarter of 2027. The planned mid-2027 Phase 1 trial for AKTX-101 is explicitly contingent on raising additional financing, so the timeline slips without a capital raise. Q3 operating expenses fell to $4.7M from $7.4M and the net loss narrowed to $4.8M from $6.4M, but the prior-year quarter included a $5.2M impairment charge, so the improvement is largely accounting-driven. GLP toxicology studies for AKTX-101 have begun, which is the one forward step here. The next hard checkpoint is financing: without new capital, the Phase 1 start does not happen.

At the time of this announcement, AKTX was trading at $6.51 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $13M. The 52-week trading range was $3.02 to $29.32. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

AKTX - Latest Insights

AKTX
Nov 12, 2026, 5:21 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.67
Real-time Price: $6.67 info
Change: $0 (0%) info
Market Cap: $13.041M info
AKTX
Nov 12, 2026, 4:00 PM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $6.51
Real-time Price: $6.67 info
Change: +$0.160 (+2%) info
Market Cap: $13.041M info
AKTX
Aug 18, 2026, 8:56 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $7.79
Real-time Price: $6.67 info
Change: -$1.12 (-14%) info
Market Cap: $13.041M info
AKTX
Aug 13, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.00
Real-time Price: $6.67 info
Change: -$0.330 (-5%) info
Market Cap: $13.041M info
AKTX
Aug 13, 2026, 4:00 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $7.00
Real-time Price: $6.67 info
Change: -$0.330 (-5%) info
Market Cap: $13.041M info